ALCON RESEARCH

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Performance Evaluation of DAILIES® TOTAL1™ in First Time Contact Lens Wearers

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: Delefilcon A contact lens

First Posted Date: 2011-12-19

Last Posted Date: 2013-07-19

Lead Sponsor: Alcon Research

Target Recruit Count: 102

Registration Number: NCT01494545

Evaluation of Marketed Contact Lens Disinfectant Systems on Eyelid Tissues

Not Applicable

Completed

Conditions: Contact Lens Care

Interventions: Device: Hydrogen peroxide-based contact lens care system
Device: PHMB-containing contact lens solution
Device: Soft contact lenses

First Posted Date: 2011-12-19

Last Posted Date: 2013-09-27

Lead Sponsor: Alcon Research

Target Recruit Count: 79

Registration Number: NCT01494818

Efficacy of Changing to TRAVATAN® From Prior Therapy

Phase 4

Completed

Conditions: Open-Angle Glaucoma
Ocular Hypertension

Interventions: Drug: Travoprost 0.004%

First Posted Date: 2011-12-16

Last Posted Date: 2014-05-19

Lead Sponsor: Alcon Research

Target Recruit Count: 202

Registration Number: NCT01493427

A Multicenter Study of the Pigmentation in the Trabecular Meshwork After Two Years of Treatment With TRAVATAN 0.004% Ophthalmic Solution

Terminated

Conditions: Open-angle Glaucoma

Interventions: Procedure: Trabecular Meshwork Tissue Collection
Drug: Travoprost 0.004% ophthalmic solution

First Posted Date: 2011-12-06

Last Posted Date: 2013-05-14

Lead Sponsor: Alcon Research

Target Recruit Count: 88

Registration Number: NCT01485822

AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure

Phase 4

Completed

Conditions: Glaucoma

Interventions: Drug: Brinzolamide 1% and timolol 0.5% fixed combination eye drops

First Posted Date: 2011-12-05

Last Posted Date: 2013-05-01

Lead Sponsor: Alcon Research

Target Recruit Count: 74

Registration Number: NCT01484951

Locations: 🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States

Lens Wearing Experience and Biocompatibility of a Marketed Multi-Purpose Disinfecting Solution in Silicone Hydrogel and Soft Contact Lens Wearers

Not Applicable

Completed

Conditions: Refractive Error

Interventions: Device: OPTI-FREE PureMoist

First Posted Date: 2011-12-05

Last Posted Date: 2012-10-10

Lead Sponsor: Alcon Research

Target Recruit Count: 175

Registration Number: NCT01484938

Locations: 🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States

In Vivo Measurement of Corneal Epithelial Changes in Dry Eye Patients

Not Applicable

Completed

Conditions: Dry Eye Syndrome

Interventions: Other: SYSTANE® Gel Drop lubricant eye gel

First Posted Date: 2011-12-02

Last Posted Date: 2016-11-18

Lead Sponsor: Alcon Research

Target Recruit Count: 19

Registration Number: NCT01483989

Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model

Phase 3

Completed

Conditions: Allergic Conjunctivitis

Interventions: Drug: AL-4943A ophthalmic solution
Drug: AL-4943A vehicle
Drug: Olopatadine hydrochloride ophthalmic solution, 0.2%

First Posted Date: 2011-11-24

Last Posted Date: 2013-06-04

Lead Sponsor: Alcon Research

Target Recruit Count: 397

Registration Number: NCT01479374

Lens Wearing Experience and Biocompatibility of a Multi-Purpose Disinfecting Solution (MPDS)

Not Applicable

Completed

Conditions: Healthy

Interventions: Device: OPTI-FREE PureMoist multipurpose disinfecting solution

First Posted Date: 2011-11-22

Last Posted Date: 2012-11-19

Lead Sponsor: Alcon Research

Target Recruit Count: 125

Registration Number: NCT01476722

Locations: 🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States

Patient Preference Comparison of AZARGA Versus COSOPT in Patients With Glaucoma

Phase 4

Completed

Conditions: Glaucoma

Interventions: Drug: Brinzolamide/Timolol Maleate Fixed Combination (AZARGA)
Drug: Dorzolamide/timolol Maleate Fixed Combination (COSOPT)

First Posted Date: 2011-11-15

Last Posted Date: 2016-11-21

Lead Sponsor: Alcon Research

Target Recruit Count: 120

Registration Number: NCT01471158

Locations: 🇦🇷
Centro Oftalmológico, Buenos Aires, Argentina

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy